AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

SteamOne - Prospective Database for Rezum Water Vapor Therapy of the Prostate

Recruitingn/aAges 18 Years - anyMaleUniversity Hospital, Basel, Switzerland
💬

In plain words

What the trial is, and whether it could suit you

This study is to assess the clinical data of Rezum (water vapor therapy) in patients with BPO (benign prostate obstruction) and male LUTS (lower urinary tract symptoms) in terms of efficacy, durability and safety in a large, prospective, multi-center cohort consisting of 1000 "real-life" patients with a follow-up of 5 years.

Sign in to get the eligibility rules as simple questions to take to your doctor.

📋 Eligibility rules (as published)
Inclusion Criteria: * All male patients who are treated with Rezum due to prostate obstruction and LUTS in the participating study centers can be included if certain inclusion criteria are met and some exclusion criteria are not present. * The indication to perform Rezum needs to be made independently from the study. The decision for Rezum treatment is the responsibility of each individual practitioner and patient. * Age ≥ 18 years * Operated or supervision of surgery by a certified urologist * Subgroups of special interest are e.g. catheter-dependent patients, patients with oral anticoagulation, patients with preoperative urodynamic pressure-flow investigation (not older than 6 months) or patients with prostates bigger than 80 ml Exclusion Criteria: * Missing informed consent * Lack of ability to answer questionnaires due to laguage problems or mental incapacity (e.g. in dementia, mental disability) * Patient does not have a personal email address available and the survey cannot be completed via a relative's email address and the patient is not willing to complete the survey on the tablet at the clinic * Known or suspected neurogenic bladder dysfunction in e.g. Parkinson's disease, multiple sclerosis or other neurological diseases with possible effects on bladder function * History of malignant bladder tumor in the last two years (including CIS) or currently present malignant bladder tumor at time of Rezum treatment (including CIS) * Previous operation(s) on the prostate, except prostate biopsy, if this was performed more than 4 weeks ago at time of Rezum treatment * Previous operation(s) on the bladder neck * Presence of bladder neck stenosis requiring treatment at time of Rezum treatment * Planned combination of Rezum treatment concurrently with another urologic (\*) or non-urologic procedure (\*) also the combination with a planned transurethral procedure is not allowed except for bladder stone removal
💊

What it tests

  • Collection and evaluation of clinical (CROMs) and patient-reported outcomes (PROMs)
  • Analysis of uroflowmetry data by EmanoFlow Mobile Application (App) and Emano Clinic Portal
📍

Where

19 sites
Universitätsklinikum Graz
Graz, Austria
Alexianer St. Hedwig-Krankenhaus
Berlin, Germany
Universitätsklinikum Frankfurt
Frankfurt, Germany
Universitätsklinikum Hamburg-Eppendorf (UKE),
Hamburg, Germany
Asklepios Westklinikum Hamburg GmbH
Hamburg, Germany
Urologische Gemeinschaftspraxis Prüner Gang
Kiel, Germany
Krankenhaus Maria Hilf - Alexianer Krefeld
Krefeld, Germany
Klinikum Nürnberg
Nuremberg, Germany

…and 11 more on ClinicalTrials.gov.

🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy